UnitedHealthcare's bold effort to deal with cancer drug costs
Burns, J.
Managed Care 20(1): 12-14; 16
2011
ISSN/ISBN: 1062-3388 PMID: 21309397 Document Number: 651869
Document emailed within 1 workday
Related Documents
Schiff, J. 2016: Patently perturbed. Trans-Pacific Partnership trade deal raises fears about drug patent periods, higher costs Modern Healthcare 46(23): 36-382012: Costs for traditional meds static while specialty drug costs soar Managed Care 21(6): 47
Kile, D.M.; McGrath, M.E.; Schindel, L.P. 1987: Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs Hospital Formulary 22(2): 176; 178, 181
Collins, R.E. 1995: Surgeons and the new deal--good deal or raw deal? Annals of the Royal College of Surgeons of England 77(6 Suppl): 297-298
Rabøl, R.; Kolbye, A.; Andersen, S.Ejdrup. 2003: Drug costs in departments of internal medicine. An analysis of costs for patients and departments Ugeskrift for Laeger 165(15): 1565-1568
Honda, M. 2011: Cancer Survivorship: the patient and medical care staff - how will society deal with cancer ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(7): 1067-1072
Lee, J. 2014: Assessing drug value. Hospitals take steps to control drug costs and aid patients Modern Healthcare 44(48): 22; 24-25
Scott, L. 1995: Effort to privatize drug reviews grows Modern Healthcare 25(26): 54
Davis-Jacobsen, D.; Plemons, C. 2008: Real-time claim adjudication: deal or no deal? Journal of Medical Practice Management: Mpm 23(4): 222-224
Andreasen, J. 2003: Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities Ugeskrift for laeger 165(29): 2873-2876
Metelitsa, V.I.; Martsevich, S.I.; Kutishenko, N.P.; Kozyreva, M.P.; Blagodatskikh, S.V.; Simkhaev, L.S.; Slastnikova, I.D.; Vakulovskaia, M.K. 1994: The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort Terapevticheskii Arkhiv 66(8): 22-25
Usman Iqbal, S.; Prashker, M. 2004: Health services research in rheumatology: a great deal accomplished, a great deal left to do Rheumatic Diseases Clinics of North America 30(4): 879-898 Viii
Novo, S.; Liquori, M.; Abrignani, M.G.; Giuliano, F.; Panno, V.; Fazio, M.; Adamo, L.; Corda, M.; Indovina, A.; di Maria, G. 1991: Acute effects of transdermal administration of nitroglycerin on effort tolerance and myocardial perfusion, evaluated by Tl-201 scintigraphy, in patients with stable effort angina Cardiologia 36(9): 693-702
Andersen, V. 1993: Drug costs Ugeskrift for Laeger 155(42): 3398-3399
Ferschneider, M.; Moulin, A. 2023: Listening Effort in Quiet and Noisy Environments in the Daily Life of Adults with Hearing Aids: An Extended Version of the Effort Assessment Scale (EEAS) Trends in Hearing 27: 23312165231176320
Okamura, H. 2010: Education for medical professionals who deal with mental care of cancer patients Seishin Shinkeigaku Zasshi 112(10): 1024-1028
Lexchin, J. 1989: Reducing drug costs New Zealand Medical Journal 102(872): 387
Jerome, D.; Laurent, C.; Catherine, B.; Didier, S.; Bertrand, C.; Muriel, R.; Joseph, M.; Olivier, Z.; Thiery, P.; Claude, C.J.an 2002: Costs of hospital management of hepatitis C virus cirrhosis in France Comparison between real costs and diagnosis related groups based costs Results of a multicentric study carried out on 267 consecutive patients in 1998 Hepatology 36(4 Part 2): 587A
Schwartz, H. 1981: Medical costs and the drug industry Medical Times 109(3): 21s-24s; 28s
Bourla, A.; Johnson, S.R. 2015: Pharma 'could have done a better job' explaining drug costs Modern Healthcare 45(50): 30-31